# Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

> **NCT00005974** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 18 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** alvocidib

## Key facts

- **NCT ID:** NCT00005974
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07-04
- **Primary completion:** 2002-11-07
- **Final completion:** 2008-09-22
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005974, "Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00005974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*